Balance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 2,161,786,000 US dollars
- Current assets
- 2,044,606,000 US dollars
- Non-current assets
- 117,180,000 US dollars
- Liabilities
- 3,815,291,000 US dollars
- Current liabilities
- 977,237,000 US dollars
- Non-current liabilities
- 2,838,054,000 US dollars
- Shareholders' deficit
- negative 1,652,142,000 US dollars
- Redeemable convertible noncontrolling interests
- negative 1,363,000 US dollars
- Noncontrolling interest
- 10,200,000 US dollars. Included in consolidated equity; this amount is not added again.
- Cash and cash equivalents
- 1,533,363,000 US dollars
- Accounts receivable, net
- 375,089,000 US dollars
- Prepaid expenses and other current assets
- 70,944,000 US dollars
- Inventories
- 59,718,000 US dollars
- Marketable securities
- 5,492,000 US dollars
- Equity method investments
- 47,783,000 US dollars
- Intangible assets, net
- 25,923,000 US dollars
- Other assets
- 22,686,000 US dollars
- Operating lease right-of-use assets
- 15,746,000 US dollars
- Property and equipment, net
- 5,042,000 US dollars
- 2027 Notes, net - 2027 Notes, net
- 548,430,000 US dollars
- Other current liabilities
- 212,114,000 US dollars
- Accounts payable
- 88,258,000 US dollars
- Accrued compensation and benefits
- 66,686,000 US dollars
- Accrued research and development liabilities
- 55,018,000 US dollars
- Deferred revenue, current portion
- 4,744,000 US dollars
- Operating lease liabilities, current portion
- 1,987,000 US dollars
- Deferred royalty obligations, net
- 884,053,000 US dollars
- 2027 Notes, 2029 Notes, 2031 Notes and 2033 Notes - 2029 Notes, net
- 742,437,000 US dollars
- 2027 Notes, 2029 Notes, 2031 Notes and 2033 Notes - 2033 Notes, net
- 620,533,000 US dollars
- 2027 Notes, 2029 Notes, 2031 Notes and 2033 Notes - 2031 Notes, net
- 566,013,000 US dollars
- Operating lease liabilities, net of current portion
- 14,645,000 US dollars
- Deferred revenue, net of current portion
- 8,968,000 US dollars
- Other long-term liabilities
- 1,405,000 US dollars
- 2027 Notes, 2029 Notes, 2031 Notes and 2033 Notes - 2027 Notes, net
- 0 US dollars
- Additional paid-in capital
- 2,170,006,000 US dollars
- Undesignated preferred stock and Series A preferred stock - Series A Cumulative Convertible Participating Preferred Stock
- 942,478,000 US dollars
- Common stock, $0.001 par value; 500,000,000 shares authorized; 198,759,831 shares issued and 192,633,286 shares outstanding as of June 30, 2026, 202,369,129 shares issued and 194,771,957 shares outstanding as of December 31, 2025
- 207,000 US dollars
- Undesignated preferred stock and Series A preferred stock - Undesignated Preferred Stock
- 0 US dollars
- Noncontrolling interests
- 10,200,000 US dollars
- Accumulated deficit
- negative 4,194,163,000 US dollars
- Treasury stock, at cost; 7,597,172 shares as of June 30, 2026; 7,597,172 shares as of December 31, 2025
- negative 580,775,000 US dollars
- Accumulated other comprehensive income (loss)
- negative 95,000 US dollars